Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 01, 2015 4:16 AM ET

Biotechnology

Company Overview of Introgen Therapeutics Inc.

Executive Profile

David G. Nance

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
63--

Background

David G. Nance served as the Chief Executive Officer and President of Introgen Therapeutics Inc. from its inception in June 1993 to November 2008. From 1992 to 1996, Mr. Nance served as Managing Partner of Texas Biomedical Development Partners, the investment group that founded Introgen Therapeutics Inc. He served as the Chairman of Introgen Therapeutics Inc. from June 5, 2007 to March 11, 2009. Mr. Nance serves as a Director of Gendux Pharmaceuticals Ltd. He also serves ...

Corporate Headquarters

8066 El Rio
Houston, Texas 77054

United States

Phone: 713-842-1017
Fax: 713-842-6660

Board Members Memberships

Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Introgen Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.